Physician profile
William Pierce
NPI 1497838593
$1,030.14
in general payments reported to CMS, 2019-2025
20 companies · $77.61 in 2025
The $77.61 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $99.06 · 2021: $263 · 2022: $239 · 2023: $62.88 · 2024: $141 · 2025: $77.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $183.72 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $138.48 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $86.80 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $68.99 | 2024 | Rexulti |
| Astrazeneca Pharmaceuticals Lp | $67.37 | 2023-2024 | Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $66.67 | 2021 | |
| Exact Sciences Corporation | $60.00 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $47.23 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.09 | 2022-2024 | Trulance, Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $42.26 | 2022 | |
| Hikma Pharmaceuticals USA | $34.75 | 2022 | |
| Genentech USA, INC. | $30.58 | 2021-2022 | |
| Allergan, INC. | $28.40 | 2019 | |
| Novo Nordisk INC | $28.30 | 2020 | |
| Sunovion Pharmaceuticals INC. | $17.77 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $17.51 | 2025 | Zenpep |
| Biodelivery Sciences International, INC. | $17.15 | 2019 | |
| Ibsa Pharma INC. | $16.25 | 2020 | |
| Collegium Pharmaceutical, INC. | $15.57 | 2020 | |
| Teleflex LLC | $15.25 | 2023 | Manta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.